Alnylam, Inceptive in AI Collaboration to Accelerate Discovery of RNAi Therapies

− Collaboration is valued at up to $2B with upfront consideration of $30M −

− Alliance pairs Alnylam’s RNAi platform and 20+ years of proprietary data with Inceptive’s foundation models and AI expertise to catalyze progress beyond rational drug design –

− Partnership designed to accelerate timelines and unlock innovative oligonucleotide designs −

https://ca.finance.yahoo.com/news/alnylam-inceptive-form-strategic-ai-204500553.html